100 Recruiting Studies Using Vincristine
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Vincristine
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
📍 University of Florida Proton Therapy Institute — Jacksonville, Florida
Rhabdomyosarcoma
View Study & Checklist ➔Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients
📍 MorphoSys Research Site — Daphne, Alabama
Diffuse Large B-cell Lymphoma
View Study & Checklist ➔Evolutionary Therapy for Rhabdomyosarcoma
📍 University of Alabama at Birmingham Comprehensive Cancer Center — Birmingham, Alabama
Rhabdomyosarcoma
View Study & Checklist ➔A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
📍 University of Arizona Cancer Center - North Campus /ID# 227463 — Tucson, Arizona
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia
📍 City of Hope Medical Center — Duarte, California
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Adult T Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)
📍 Research Site — Tucson, Arizona
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
View Study & Checklist ➔Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma
📍 Cleveland Clinic — Cleveland, Ohio
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Recurrent B Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study of N9 Chemotherapy in Children With Neuroblastoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Neuroblastoma
View Study & Checklist ➔A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
📍 Cohen Children's Medical Center of New York — New Hyde Park, New York
Pilomyxoid Astrocytoma
View Study & Checklist ➔Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
📍 Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
📍 Children's Hospital of Alabama ( Site 0023) — Birmingham, Alabama
Hodgkin Lymphoma
View Study & Checklist ➔Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Alveolar Rhabdomyosarcoma
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
📍 Local Institution - 0152 — Birmingham, Alabama
Lymphoma, Follicular
View Study & Checklist ➔Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Aggressive Non-Hodgkin Lymphoma
View Study & Checklist ➔Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
📍 Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Grade 1 Follicular Lymphoma
View Study & Checklist ➔Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma
📍 City of Hope (City of Hope National Medical Center, City of Hope Medical Center) — Duarte, California
Relapsed/Refractory Follicular Lymphoma
View Study & Checklist ➔Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
Mantle Cell Lymphoma
View Study & Checklist ➔Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
View Study & Checklist ➔Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma
📍 University of Alabama Hospital — Birmingham, Alabama
High-risk Large B-cell Lymphoma (LBCL)
View Study & Checklist ➔Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Alveolar Rhabdomyosarcoma
View Study & Checklist ➔Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
📍 Banner University Medical Center - Tucson — Tucson, Arizona
Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
📍 Providence Hospital — Mobile, Alabama
Ann Arbor Stage II Non-Hodgkin Lymphoma
View Study & Checklist ➔Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
Blastoid Variant Mantle Cell Lymphoma
View Study & Checklist ➔Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors
📍 Lucille Packard Children's Hospital at Stanford University Medical Center — Palo Alto, California
Malignant Rhabdoid Tumor
View Study & Checklist ➔Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Recurrent B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies
📍 University of Texas Southwestern — Dallas, Texas
B-cell Lymphoma
View Study & Checklist ➔Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study
📍 M D Anderson Cancer Center — Houston, Texas
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Sarcoma
View Study & Checklist ➔Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Recurrent Adult Lymphoblastic Lymphoma
View Study & Checklist ➔A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Leukemia
View Study & Checklist ➔A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Low Grade Glioma
View Study & Checklist ➔Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
📍 Boston Children's Hospital — Boston, Massachusetts
Acute Lymphoblastic Leukemia, Pediatric
View Study & Checklist ➔Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
📍 UCSF Fresno /ID# 264712 — Fresno, California
Follicular Lymphoma (FL)
View Study & Checklist ➔A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma
📍 Boca Raton Clinical Research (BRCR) Global — Plantation, Florida
Follicular Lymphoma (FL)
View Study & Checklist ➔Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Medulloblastoma
View Study & Checklist ➔Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
📍 Children's Hospital of Alabama — Birmingham, Alabama
Childhood Hepatocellular Carcinoma
View Study & Checklist ➔Vincristine Pharmacokinetics in Infants
📍 Children's Hospital of Alabama — Birmingham, Alabama
Hematopoietic and Lymphoid Cell Neoplasm
View Study & Checklist ➔Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
Retinoblastoma
View Study & Checklist ➔Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Primary Mediastinal Large B-Cell Lymphoma
View Study & Checklist ➔Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Brain and Central Nervous System Tumors
View Study & Checklist ➔Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Lymphoma
View Study & Checklist ➔A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
📍 Lucille Packard Children's Hospital at Stanford University Medical Center — Palo Alto, California
Medulloblastoma
View Study & Checklist ➔Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma
📍 Local Institution - 0014 — Mobile, Alabama
Large B-cell Lymphoma
View Study & Checklist ➔Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment
📍 Wake Forest University Health Sciences — Winston-Salem, North Carolina
B-Cell Non-Hodgkin Lymphoma
View Study & Checklist ➔PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
📍 Children's Hospital Los Angeles — Los Angeles, California
ALL, Childhood
View Study & Checklist ➔Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body
📍 Children's Hospital of Alabama — Birmingham, Alabama
CIC-Rearranged Sarcoma
View Study & Checklist ➔Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Primary Effusion Lymphoma
View Study & Checklist ➔Split-Dose R-CHOP for Older Adults With DLBCL
📍 University of Wisconsin Carbone Cancer Center — Madison, Wisconsin
Diffuse Large B Cell Lymphoma
View Study & Checklist ➔Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Metastatic Ewing Sarcoma
View Study & Checklist ➔A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham — Birmingham, Alabama
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
View Study & Checklist ➔Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Ann Arbor Stage IIB Hodgkin Lymphoma
View Study & Checklist ➔Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
📍 Memorial Sloan Kettering Cancer Center Basking Ridge — Basking Ridge, New Jersey
Newly Diagnosed Ewing Sarcoma
View Study & Checklist ➔International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry
📍 Anne K Harris — Minneapolis, Minnesota
Pleuropulmonary Blastoma
View Study & Checklist ➔Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
📍 Local Institution - 162 — Birmingham, Alabama
Lymphoma, B-Cell
View Study & Checklist ➔Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
📍 Banner University Medical Center - Tucson — Tucson, Arizona
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
📍 Children's Hospital Los Angeles — Los Angeles, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
Hodgkin Lymphoma
View Study & Checklist ➔Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
📍 NCI Lymphoid Malignancies Branch — Bethesda, Maryland
AIDS-Related Burkitt Lymphoma
View Study & Checklist ➔Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Refractory Acute Lymphoblastic Leukemia
View Study & Checklist ➔Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
📍 UC San Diego Moores Cancer Center — La Jolla, California
AIDS-Related Lymphoma
View Study & Checklist ➔A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Recurrent Acute Leukemia of Ambiguous Lineage
View Study & Checklist ➔Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Lymphoproliferative Disorder
View Study & Checklist ➔Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Adult Burkitt Lymphoma
View Study & Checklist ➔N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
High-risk Neuroblastoma
View Study & Checklist ➔A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
📍 Children's Hospital of Alabama — Birmingham, Alabama
Anaplastic Kidney Wilms Tumor
View Study & Checklist ➔Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
📍 University of Chicago Medical Center — Chicago, Illinois
Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma
📍 University of Rochester — Rochester, New York
DLBCL
View Study & Checklist ➔Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
📍 Novant Health Presbyterian Hemby Children's Hospital — Charlotte, North Carolina
Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
📍 Research Site — Boston, Massachusetts
Chronic Lymphocytic Leukaemia
View Study & Checklist ➔The CARDIOPROTECT Trial
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
Diffuse Large B-cell Lymphoma (DLBCL)
View Study & Checklist ➔Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
View Study & Checklist ➔A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
📍 Children's Hospital of Alabama — Birmingham, Alabama
Stage I Mixed Cell Type Kidney Wilms Tumor
View Study & Checklist ➔PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
📍 Cedars-Sinai Medical Center — Los Angeles, California
Refractory Solid Tumors
View Study & Checklist ➔A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
📍 Mayo Clinic - Arizona — Scottsdale, Arizona
Diffuse Large B-cell Lymphoma (DLBCL)
View Study & Checklist ➔A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
📍 University of Miami Miller School of Medicine — Miami, Florida
Plasmablastic Lymphoma
View Study & Checklist ➔A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study
📍 MD Anderson Cancer Center — Houston, Texas
Peripheral T Cell Lymphoma
View Study & Checklist ➔Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Leukemia
View Study & Checklist ➔A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
📍 Children's Hospital of Alabama — Birmingham, Alabama
Rhabdomyosarcoma
View Study & Checklist ➔Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
📍 Lucille Packard Children's Hospital Stanford — Palo Alto, California
Medulloblastoma
View Study & Checklist ➔Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
📍 Rady Children's Hospital — San Diego, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
📍 University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
Acute Leukemia
View Study & Checklist ➔A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
📍 Children's Hospital of Alabama — Birmingham, Alabama
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
View Study & Checklist ➔Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Diffuse Large Cell Lymphoma
View Study & Checklist ➔Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
📍 Rady Children's Hospital — San Diego, California
T-cell Acute Lymphoblastic Leukemia
View Study & Checklist ➔Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔